Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Robustness testing and optimization of an adverse outcome pathway on cholestatic liver injury
Future Directions Research efforts continue to focus on uncovering the underlying causes of IC and developing more effective and personalized treatment options
Limit 3 per person
Rather than being an either-or choice for most patients, metformin often serves as the foundation while a GLP-1 agonist is added if blood sugar targets are not met or if additional cardiovascular, renal, or weight benefits are needed
US$ 21.27
US$ 22.19
US$ 20.08
US$ 28.74
US$ 23.01
US$ 25.45
